PON1 and liver disorder: The potential impact of these confounding factors underscores the need for a nuanced approach in evaluating PON-1 as a biomarker in dogs with hepatic disorders, highlighting the necessity for additional investigations to delineate the specific circumstances under which PON-1 activity may be reliably interpreted in the context of liver pathology.